Skip to main content
Erschienen in: Shape Memory and Superelasticity 2/2022

19.07.2022 | Technical Article

Active Wearable Compression with Shape Memory Actuators for Treating Chronic Edema

verfasst von: John Pamplin, Jarren Baldwin, Julia Rodrick, Anand Doraiswamy, OTR/L, CLT-LANA, WCC

Erschienen in: Shape Memory and Superelasticity | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Chronic edema can occur from impairment of the lymphatic, arterial, and venous systems. It can be a lifelong condition where self-care and treatment are necessary to manage the progressive worsening of the disease, which can lead to increased risk for infection, cellulitis, ulceration, wound, and amputation. At-home treatment options for this chronic debilitating disease are very limited. Existing PCDs have been around for several decades and have several major disadvantages. SMA embodied in a novel NPCD format allows for opportunity to address some of these disadvantages. Comparison of the two types of compression devices SMA-based NPCD and traditional PCD are evaluated and discussed in this study. Pressures were compared on both silicon and human subjects and visualization of applied pressure was also analyzed. Both devices provide comparable pressure range though PCD has higher variability in terms of uniformity of pressure applied. NPCD using SMA offers new treatment opportunity for patients with chronic edema at home in an entirely mobile and wearable platform.
Literatur
2.
Zurück zum Zitat Szuba A, Rockson SG (1997) Lymphedema: anatomy, physiology and pathogenesis. Vasc Med 2:321–326CrossRef Szuba A, Rockson SG (1997) Lymphedema: anatomy, physiology and pathogenesis. Vasc Med 2:321–326CrossRef
4.
Zurück zum Zitat Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114:806–816CrossRef Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Int J Cancer 114:806–816CrossRef
7.
Zurück zum Zitat Noone A-M, Cronin KA, Altekruse SF, Howlader N, Lewis DR, Petkov VI, Penberthy L (2017) Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992–2013. Cancer Epidemiol Prevent Biomark 26:632–641CrossRef Noone A-M, Cronin KA, Altekruse SF, Howlader N, Lewis DR, Petkov VI, Penberthy L (2017) Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992–2013. Cancer Epidemiol Prevent Biomark 26:632–641CrossRef
8.
Zurück zum Zitat Fu MR (2014) Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. World J Clin Oncol 5:241CrossRef Fu MR (2014) Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management. World J Clin Oncol 5:241CrossRef
9.
Zurück zum Zitat Fu MR, Rosedale M (2009) Breast cancer survivors’ experiences of lymphedema-related symptoms. J Pain Symptom Manage 38:849–859CrossRef Fu MR, Rosedale M (2009) Breast cancer survivors’ experiences of lymphedema-related symptoms. J Pain Symptom Manage 38:849–859CrossRef
10.
Zurück zum Zitat International Society of Lymphology (2003) The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology 36:84–91 International Society of Lymphology (2003) The diagnosis and treatment of peripheral lymphedema. Consensus document of the International Society of Lymphology. Lymphology 36:84–91
11.
Zurück zum Zitat Armer JM, Radina ME, Porock D, Culbertson SD (2003) Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 52:370–379CrossRef Armer JM, Radina ME, Porock D, Culbertson SD (2003) Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 52:370–379CrossRef
12.
Zurück zum Zitat Mayrovitz HN (2009) The standard of care for lymphedema: current concepts and physiological considerations. Lymphat Res Biol 7:101–108CrossRef Mayrovitz HN (2009) The standard of care for lymphedema: current concepts and physiological considerations. Lymphat Res Biol 7:101–108CrossRef
13.
Zurück zum Zitat Lawenda BD, Mondry TE, Johnstone PA (2009) Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. A Cancer J Clin 59:8–24CrossRef Lawenda BD, Mondry TE, Johnstone PA (2009) Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. A Cancer J Clin 59:8–24CrossRef
14.
Zurück zum Zitat International Lymphoedema Framework (2006) Best practice for the management of lymphoedema. International Consensus. London: MEP Ltd 3–52 International Lymphoedema Framework (2006) Best practice for the management of lymphoedema. International Consensus. London: MEP Ltd 3–52
15.
Zurück zum Zitat Cormier J, Feldman J, Askew R, Beck M, Bernas M, Francis K, Fu M, Lasinski B, Rodrick J, Stewart B (2010) ALFP to update the best practice document. J Lymphoedema 5:68–71 Cormier J, Feldman J, Askew R, Beck M, Bernas M, Francis K, Fu M, Lasinski B, Rodrick J, Stewart B (2010) ALFP to update the best practice document. J Lymphoedema 5:68–71
16.
Zurück zum Zitat Lurie F, Malgor RD, Carman T, Dean SM, Iafrati MD, Khilnani NM, Labropoulos N, Maldonado TS, Mortimer P, O’Donnell TF Jr, Raffetto JD, Rockson SG, Gasparis AP (2022) The American Venous Forum, American Vein and lymphatic society and the society for vascular medicine expert opinion consensus on lymphedema diagnosis and treatment. Phlebology 37(4):252–266. https://doi.org/10.1177/02683555211053532CrossRef Lurie F, Malgor RD, Carman T, Dean SM, Iafrati MD, Khilnani NM, Labropoulos N, Maldonado TS, Mortimer P, O’Donnell TF Jr, Raffetto JD, Rockson SG, Gasparis AP (2022) The American Venous Forum, American Vein and lymphatic society and the society for vascular medicine expert opinion consensus on lymphedema diagnosis and treatment. Phlebology 37(4):252–266. https://​doi.​org/​10.​1177/​0268355521105353​2CrossRef
17.
Zurück zum Zitat Ridner SH, Murphy B, Deng J, Kidd N, Galford E, Bonner C, Bond SM, Dietrich MS (2012) A randomized clinical trial comparing advanced pneumatic truncal, chest, and arm treatment to arm treatment only in self-care of arm lymphedema. Breast Cancer Res Treat 131:147–158CrossRef Ridner SH, Murphy B, Deng J, Kidd N, Galford E, Bonner C, Bond SM, Dietrich MS (2012) A randomized clinical trial comparing advanced pneumatic truncal, chest, and arm treatment to arm treatment only in self-care of arm lymphedema. Breast Cancer Res Treat 131:147–158CrossRef
18.
Zurück zum Zitat Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH (2015) The cutaneous, net clinical, and health economic benefits of advanced pneumatic compression devices in patients with lymphedema. JAMA Dermatol 151:1187–1193CrossRef Karaca-Mandic P, Hirsch AT, Rockson SG, Ridner SH (2015) The cutaneous, net clinical, and health economic benefits of advanced pneumatic compression devices in patients with lymphedema. JAMA Dermatol 151:1187–1193CrossRef
19.
Zurück zum Zitat Adams KE, Rasmussen JC, Darne C, Tan I-C, Aldrich MB, Marshall MV, Fife CE, Maus EA, Smith LA, Guilloid R (2010) Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express 1:114–125CrossRef Adams KE, Rasmussen JC, Darne C, Tan I-C, Aldrich MB, Marshall MV, Fife CE, Maus EA, Smith LA, Guilloid R (2010) Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express 1:114–125CrossRef
20.
Zurück zum Zitat Wilburn O, Wilburn P, Rockson SG (2006) A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. BMC Cancer 6:1–10CrossRef Wilburn O, Wilburn P, Rockson SG (2006) A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. BMC Cancer 6:1–10CrossRef
21.
Zurück zum Zitat Fife CE, Davey S, Maus EA, Guilliod R, Mayrovitz HN (2012) A randomized controlled trial comparing two types of pneumatic compression for breast cancer-related lymphedema treatment in the home. Support Care Cancer 20:3279–3286CrossRef Fife CE, Davey S, Maus EA, Guilliod R, Mayrovitz HN (2012) A randomized controlled trial comparing two types of pneumatic compression for breast cancer-related lymphedema treatment in the home. Support Care Cancer 20:3279–3286CrossRef
22.
Zurück zum Zitat Hammond T (2009) Reduction of complications and associated costs with Flexitouch® therapy for lymphedema. The Open Rehabilitation Journal 2:54–57CrossRef Hammond T (2009) Reduction of complications and associated costs with Flexitouch® therapy for lymphedema. The Open Rehabilitation Journal 2:54–57CrossRef
23.
Zurück zum Zitat Ridner SH, McMahon E, Dietrich MS, Hoy S (2008) Home-based lymphema treatment in patients with cancer-related lymphedema or non cancer-related lymphedema. Oncol Nurs Forum 35(4):671–680CrossRef Ridner SH, McMahon E, Dietrich MS, Hoy S (2008) Home-based lymphema treatment in patients with cancer-related lymphedema or non cancer-related lymphedema. Oncol Nurs Forum 35(4):671–680CrossRef
24.
Zurück zum Zitat Blumberg SN, Berland T, Rockman C, Mussa F, Brooks A, Cayne N, Maldonado T (2016) Pneumatic compression improves quality of life in patients with lower-extremity lymphedema. Ann Vasc Surg 30:40–44CrossRef Blumberg SN, Berland T, Rockman C, Mussa F, Brooks A, Cayne N, Maldonado T (2016) Pneumatic compression improves quality of life in patients with lower-extremity lymphedema. Ann Vasc Surg 30:40–44CrossRef
25.
Zurück zum Zitat Brayton KM, Hirsch AT, Patricia J, Cheville A, Karaca-Mandic P, Rockson SG (2014) Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs. PLoS ONE 9:114597CrossRef Brayton KM, Hirsch AT, Patricia J, Cheville A, Karaca-Mandic P, Rockson SG (2014) Lymphedema prevalence and treatment benefits in cancer: impact of a therapeutic intervention on health outcomes and costs. PLoS ONE 9:114597CrossRef
27.
Zurück zum Zitat Boris, M.; Weindorf, S. (1997) Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Cancer 11 Boris, M.; Weindorf, S. (1997) Persistence of lymphedema reduction after noninvasive complex lymphedema therapy. Cancer 11
28.
Zurück zum Zitat Rockson SG, Karaca-Mandic P, Skoracki R, Hock K, Nguyen M, Shadduck K, Gingerich P, Campione E, Leifer A, Armer J (2022) Clinical evaluation of a novel wearable compression technology in the treatment of Lymphedema, an open-label controlled study. Lymphat Res Biol 22(2):125–132CrossRef Rockson SG, Karaca-Mandic P, Skoracki R, Hock K, Nguyen M, Shadduck K, Gingerich P, Campione E, Leifer A, Armer J (2022) Clinical evaluation of a novel wearable compression technology in the treatment of Lymphedema, an open-label controlled study. Lymphat Res Biol 22(2):125–132CrossRef
29.
Zurück zum Zitat Rockson, S. G., Whitworth, P. W., Cooper, A., Kania, S., Karnofel, H., Nguyen M., Shadduck, K., Gingerich, P., Armer, J., (2022) Safety and Effectiveness of a Novel Non-Pneumatic Active Compression Device for Treating Breast Cancer-Related Lymphedema, a Multi-center Randomized, Crossover Trial. Journal of Vascular Surgery Rockson, S. G., Whitworth, P. W., Cooper, A., Kania, S., Karnofel, H., Nguyen M., Shadduck, K., Gingerich, P., Armer, J., (2022) Safety and Effectiveness of a Novel Non-Pneumatic Active Compression Device for Treating Breast Cancer-Related Lymphedema, a Multi-center Randomized, Crossover Trial. Journal of Vascular Surgery
Metadaten
Titel
Active Wearable Compression with Shape Memory Actuators for Treating Chronic Edema
verfasst von
John Pamplin
Jarren Baldwin
Julia Rodrick
Anand Doraiswamy
OTR/L, CLT-LANA, WCC
Publikationsdatum
19.07.2022
Verlag
Springer US
Erschienen in
Shape Memory and Superelasticity / Ausgabe 2/2022
Print ISSN: 2199-384X
Elektronische ISSN: 2199-3858
DOI
https://doi.org/10.1007/s40830-022-00379-w

Weitere Artikel der Ausgabe 2/2022

Shape Memory and Superelasticity 2/2022 Zur Ausgabe

    Marktübersichten

    Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.